C
Chronus Health
Portable platform for real-time diagnosis at the point-of-care providing lab results in minutes, dramatically improving patient outcomes
About Chronus Health
Chronus Health, established in 2017 by co-founders Anand Parikh and Ashish Jagtiani, is a medical technology company focused on the point-of-care diagnostics market. The inspiration for the company came from Jagtiani's personal experience with his sister's leukemia diagnosis, where he observed the frustratingly long wait times for blood test results. This led him, a PhD with a background in semiconductor devices and lab-on-a-chip technology from his time at IBM's Thomas J. Watson Research Center, to envision a faster solution. He partnered with his long-time friend, Anand Parikh, a bioengineering graduate with extensive experience in medical devices, to launch the company.
The company is developing a portable, real-time blood testing system designed to deliver lab-quality results within minutes, directly at the point of care. Chronus Health's platform operates similarly to a glucose meter, utilizing a disposable test cartridge with embedded sensors. This system sidesteps the complex and costly optical measurements of traditional, bulky blood analyzers by employing a proprietary electrical sensing approach that combines microfluidics, semiconductors, and machine learning. This enables the device to perform a wide range of tests, including complete blood counts (CBC), complete metabolic panels (CMP), chemistry assays, and immunoassays, on-site. By providing immediately actionable data, the technology aims to significantly reduce diagnosis time, improve patient outcomes, and lower overall healthcare costs.
Chronus Health targets its services toward healthcare settings where rapid blood analysis is critical but often unavailable, such as urgent care centers, skilled nursing facilities, infusion centers, retail clinics, and primary care practices. The business model centers on providing a low-cost, compact system that can handle the majority of common blood tests, challenging the market's reliance on centralized labs for analysis. The company has secured significant financial backing, raising a total of $23.6 million over four funding rounds. Its most recent major funding was a $22 million Series A round in January 2022, led by Tarsadia Investments with participation from Monta Vista Capital, SOSV, and Savantus Ventures.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 4
- Open positions
- None listed
- Dealroom signal
- 62.2/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Testing, Biotechnology, Microfluidics, Point of Care, Biotech and Pharma, medical testing, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBT✓Debt | Jan 2024 | $5M | — | Undisclosed | ↗ |
| SERIES A✓Equity / VC | Jan 2022 | $22M | $88M | Tarsadia Investments · SOSV · Monta Vista Capital · Savantus Ventures | ↗ |
Growth signals
Latest recorded traffic for Chronus Health is 110 monthly website visits, down 83.1% over the last three months. Chronus Health's team declined 20% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Chronus Health in the Fremont ecosystem
The Chronus Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
SOSV
Magic Fund
Series A3 investors entered at this stage
Tarsadia Investments
Monta Vista Capital- SVSavantus Ventures
Other known investors5 additional known investors
Indie Bio
Fogarty Institute of Innovation
Harbor Street Ventures
Plug and Play
SeedFolio
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Chronus Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Chronus Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









